article thumbnail

Sarah Ferguson Reveals Breast Cancer Diagnosis, Mastectomy

Drugs.com

MONDAY, June 26, 2023 -- Sarah Ferguson has undergone treatment for breast cancer, she announced on her podcast. The Duchess of York, 63, had a mastectomy after the diagnosis and the surgery was successful, her rep confirmed Sunday, People magazine.

Treatment 278
article thumbnail

Beyond the Lab: Cell & Gene Therapy

Drug Target Review

Dear Readers, I am thrilled to announce the launch of our new series, “Beyond the Lab,” which promises to deliver high-level insights commissioned exclusively by Drug Target Review magazine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Let’s talk neuroscience with Michelle Sidor at SFN

Drug Target Review

At Alchemab, we’re acutely aware of the challenges in discovering new treatments for complex diseases, a problem often exacerbated by the limitations of current drug development models. Our Associate Director of Neuroscience, Iosif Pediaditakis, has been responsible for delivering on this effort. Sifis: Thank you, Michelle!

article thumbnail

Mediating BRAF-mutant melanoma resistance

Drug Target Review

Rather than solely identifying tumour-associated mutations which can be specifically targeted for effective treatment, we now need to consider how non-mutational events play into both the development of the primary tumour and the development of therapy resistance.

article thumbnail

Women in Stem with Leila Jaafar

Drug Target Review

He would return from his travels with an assortment of magazines, often including a scientific journal in the mix. This breakthrough has the potential not only to spur further research in the field but also to make this revolutionary treatment widely available to patients across the globe.

article thumbnail

BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada

The Pharma Data

BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, is pleased to announce that Health Canada has confirmed that 2-bromo-LSD is not a controlled substance. VANCOUVER, Jan.

article thumbnail

ATICAPRANT

New Drug Approvals

2] Like other kappa opioid antagonists currently under clinical investigation for the treatment of major depression, its efficacy may be compromised by the countervailing activation of pro-inflammatory cytokines in microglia within the CNS. [7] 2] Aticaprant is taken by mouth. [1] nM vs. 24.0 13] [14] Occupancy was 35% for a 0.5 nM vs. 24.0